Cilnidipine - Anti-hypertensives-(June 2007)
Drug Name:
Cilnidipine - Anti-hypertensives-(June 2007)
List Of Brands:
Indication Type Description:
Drug Interaction:
Aldesleukin,
Antipychotics that cause hypotension may modify insulin and glucose responses
Quinidine, carbamazepine, phenytoin, rifampicin, cimetidine, erythromycin
Indication:
LIST OF DRUGS DURING 2007
Sr.No- 101
Name of the Drug- Cilnidipine Tabs 5mg,10mg Pharmacological Classification- For treatment of mild to moderate hypertension
Date of Approval- 21-06-07
Approved by U.S.FDA on 30-12-2007 (Ref- FDA approved List- 2007)
Hypertension
Adverse Reaction:
Dizziness, flushing, headache, hypotensions, oedema
Swelling, breathlessness, tachycardia nausea,
G-i disturbances, increased mituration frequency,
Lethargy, eye pain, rashes, depression, ischaemic chest pain,
Cerebral ischaemia, transcient blindness fever, abnormal liver function,
Gingival hyperplasia, myalgia, tremor, impotence
Contra-Indications:
Cardiogenic shock, recent MI or acute unstable angina,
Stevens aortic stenosia
Special Precautions-
Poor cardiac reserve , herat failure
Discontinue patients who experience ischaemic pain following administration
Pregnancy,
Lactation
Dosages/ Overdosage Etc:
Hypertension
Dosage-
5-10mg once daily. Max 20mg
Patient Information:
Special precautions-
Hypotension,poor cardiac reserve,heart failure.Sudden withdrawal may exacerbate angina.Discontune in patients who experience ichemic pain following administration.
Pregnancy,Lactation
Pregnancy and lactation:
Excercise Caution, if administered during pregnancy or Lactation